• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Healthcare Investors

+ Add to Watchlist

HQH:US

32.6200 USD 0.2100 0.65%

As of 17:15:06 ET on 11/28/2014.

Snapshot for Tekla Healthcare Investors (HQH)

Open: 32.5200 High - Low: 32.6700 - 32.4530 Primary Exchange: New York
Volume: 68,999 52-Week Range: 23.8571 - 32.6700 Beta vs BTK: 0.8367

ETF Chart for HQH

No chart data available.
  • HQH:US 32.6200
  • 1D
  • 1M
  • 1Y
32.4100
Interactive HQH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HQH

H&Q Healthcare Investors is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long-term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 1987-04-22 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for HQH

NAV (on 2014-11-28) 31.6300
Assets (M) (on 2014-11-28) 1,132.8020
Shares out (M) 35.82
Market Cap (M) 1,168.36
% Premium 3.13
Average 52-Week % Premium -1.5004
Fund Leveraged N

Dividends for HQH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-11-24) 0.5900
Dividend Yield (ttm) 6.74%

Performance for HQH

1-Month +9.35% 1-Year +37.32%
3-Month +17.35% 3-Year +43.94%
Year To Date +32.63% 5-Year +34.08%
Expense Ratio 1.26

Top Fund Holdings for HQH

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Idec Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil